Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI

SETTING: Nine months of daily isoniazid (9H) and 3 months of once-weekly rifapentine plus isoniazid (3HP) are recommended treatments for latent tuberculous infection (LTBI). The risk profile for 3HP and the contribution of hepatitis C virus (HCV) infection to hepatotoxicity are unclear. OBJECTIVES:...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Tuberc Lung Dis
Egile Nagusiak: Bliven-Sizemore, E. E., Sterling, T. R., Shang, N., Benator, D., Schwartzman, K., Reves, R., Drobeniuc, J., Bock, N., Villarino, M. E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5080618/
https://ncbi.nlm.nih.gov/pubmed/26260821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.14.0829
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak